Co-founder and CEO, RootPath
Xi Chen is the CEO and a co-founder of RootPath, a Cambridge, MA-based biotech company pioneering synthetic immunology and its applications in therapeutics. Before starting RootPath he served as Vice President of Nest.bio Ventures, a healthcare-oriented venture fund, and was the first employee of Ultivue. Dr. Chen has more than ten years of experience in innovative biomolecular analysis and engineering. Before moving to industry he published dozens of research articles including ones in top journals such as Nature Chemistry, PNAS, and JACS as a lead or senior author. He was a recipient of the prestigious Jane Coffin Childs Fellowship. Dr. Chen earned PhD degree in Biochemistry at University of Texas at Austin in 2010 and finished his postdoctoral training at Harvard’s Wyss Institute for Biologically Inspired Engineering in 2015.